• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total 2253 pieces (Transmittal of Advertisements and Promotional Labeling for Drugs and Biologics for Human Use) received

Dictionary: OPDP tracks the incoming volume of prescription drug promotional pieces that it receives each month. Companies are required to submit copies of the pieces they develop to promote their prescription drugs on Form FDA-2253 at the time these pieces are first publicly used (these submissions are referred to as “2253” submissions). OPDP monitors incoming 2253 submissions to examine trends in prescription drug promotion both by promotion target (e.g., consumers versus healthcare professionals) and by channel (e.g., print, broadcast, internet). For example, in recent years OPDP has seen a large increase in the volume of 2253 submissions that are internet-based, and this is one of the trends it is tracking under Measure B. This measure also provides a surrogate measure of OPDP’s potential workload by capturing the total amount of prescription drug promotion that is developed and disseminated during given periods of time; as such, it is useful to monitor to help ensure the efficient allocation of review resources within OPDP.


These measures have been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/A7,819
Nov 2011N/A7,358
Dec 2011N/A6,355
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

FY 2012 YTD: 21,532

2253s segmented by promotion target: Percent of 2253s directed to Healthcare Professionals

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetPercent
Oct 2011N/A66
Nov 2011N/A70
Dec 2011N/A65
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

2253s segmented by promotion target: Percent of 2253s directed to Consumers

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetPercent
Oct 2011N/A34
Nov 2011N/A30
Dec 2011N/A35
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

2253s segmented by promotion channel: Percent of 2253s promoted using the Internet

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetPercent
Oct 2011N/A23
Nov 2011N/A23
Dec 2011N/A27
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

2253s segmented by promotion channel: Percent of 2253s promoted using non-Internet means (Print, TV etc.)

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetPercent
Oct 2011N/A77
Nov 2011N/A77
Dec 2011N/A73
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.